Biofrontera
BFRIW
7 hedge funds and large institutions have $2.1K invested in Biofrontera in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
15.13% more ownership
Funds ownership: 0.83% → 15.95% (+15%)
0% more funds holding
Funds holding: 7 → 7 (0)
70% less capital invested
Capital invested by funds: $7K → $2.1K (-$4.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$138 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$324 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $1.88K | -$324 | -13,000 | -6% |
|
|
CS
2
Clear Street
New York
| $109 | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $90 | +$138 | +5,526 | +47% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $11 | – | – | – |
|
5
US Bancorp
Minneapolis,
Minnesota
| $10 | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $2 | +$4 | +141 | +204% |
|
7
Bank of America
Charlotte,
North Carolina
| $1 | – | – | – |
|
BFRIW Hedge Fund Activity: Q4 2023 in Review
7 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q4 2023, worth a combined $2.1K — down 70% from $7K a quarter earlier.
Fund positioning in BFRIW was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $138. The largest seller was Bard Associates, cutting an estimated $324.
- 7 institutional investors held Biofrontera (BFRIW) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $2.1K of Biofrontera stock for Q4 2023, down 70% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q4 2023 and 0 closed out.
- The largest Biofrontera buyer in Q4 2023 was Susquehanna International Group, an estimated $138 added.
- The largest Biofrontera seller in Q4 2023 was Bard Associates, an estimated $324 sold.
Based on aggregated 13F filings for Q4 2023.